Literature DB >> 21628813

Comparative study among clinical and commensal isolates of Enterococcus faecalis for presence of esp gene and biofilm production.

Giridhara P M Upadhyaya1, Umapathy B Lingadevaru, Ravikumar K Lingegowda.   

Abstract

INTRODUCTION: Because of increasing difficulty in treating enterococcal infections, effort is being devoted to understanding factors that are responsible for causing nosocomial infection, with a focus toward targeting these factors with new therapeutics. Evidence has emerged that the esp gene mediates biofilm formation in vitro, which helps the organism colonize and cause infection.
METHODOLOGY: This study was conducted over a four-year period in a tertiary-care hospital. There were 200 clinical pathogenic strains isolated from nosocomial infections and 100 commensals from stool specimens of healthy individuals. The study compared the production of biofilm and detection of the esp gene among clinical and commensal isolates.
RESULTS: Among 200 clinical isolates of Enterococcus faecalis 65 (32.5%) isolates were positive for biofilm production and 60 (30%) for the esp gene by PCR. Among 100 commensal isolates, 16 (8%) and 14 (7%) were positive for biofilm formation and the esp gene, respectively. Five clinical and two commensal isolates produced biofilm without any amplification of the esp gene.
CONCLUSION: The study shows a significant difference in production of biofilm and presence of the esp gene between clinical and commensal isolates (P < 0.002). Therefore, it can be concluded that biofilm production has an important role in causing nosocomial infection. Although detection of the esp gene correlates with biofilm production, it may not be the only factor determining the formation of biofilm since few isolates produced biofilm without the esp gene. Strains isolated from indwelling medical devices showed high production of biofilm and esp gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628813     DOI: 10.3855/jidc.1385

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  Speciation and antimicrobial resistance of Enterococci isolated from recreational beaches in Malaysia.

Authors:  Ayokunle Christopher Dada; Asmat Ahmad; Gires Usup; Lee Yook Heng
Journal:  Environ Monit Assess       Date:  2012-05-18       Impact factor: 2.513

Review 2.  Public Health Risks of Multiple-Drug-Resistant Enterococcus spp. in Southeast Asia.

Authors:  Diane Sunira Daniel; Sui Mae Lee; Gary A Dykes; Sadequr Rahman
Journal:  Appl Environ Microbiol       Date:  2015-07-06       Impact factor: 4.792

3.  Distribution of antimicrobial resistance determinants, virulence-associated factors and clustered regularly interspaced palindromic repeats loci in isolates of Enterococcus faecalis from various settings and genetic lineages.

Authors:  Iwona Gawryszewska; Katarzyna Malinowska; Alicja Kuch; Dorota Chrobak-Chmiel; Lucja Laniewska- Trokenheim; Waleria Hryniewicz; Ewa Sadowy
Journal:  Pathog Dis       Date:  2017-03-01       Impact factor: 3.166

4.  Characterization of Enterococcus faecalis isolates originating from different sources for their virulence factors and genes, antibiotic resistance patterns, genotypes and biofilm production.

Authors:  T Gulhan; B Boynukara; A Ciftci; M U Sogut; A Findik
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

5.  Virulence Genes among Enterococcus faecalis and Enterococcus faecium Isolated from Coastal Beaches and Human and Nonhuman Sources in Southern California and Puerto Rico.

Authors:  Donna M Ferguson; Ginamary Negrón Talavera; Luis A Ríos Hernández; Stephen B Weisberg; Richard F Ambrose; Jennifer A Jay
Journal:  J Pathog       Date:  2016-04-10

6.  Antibiotic Resistance and Virulence Traits in Vancomycin-Resistant Enterococci (VRE) and Extended-Spectrum β-Lactamase/AmpC-producing (ESBL/AmpC) Enterobacteriaceae from Humans and Pets.

Authors:  Ramona Iseppi; Alessandro Di Cerbo; Patrizia Messi; Carla Sabia
Journal:  Antibiotics (Basel)       Date:  2020-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.